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This study was designed to determine the effects of phlebotomy on iron body contents and coagulation tests of COPO patients with
po'ycythemia secondary to hypoxemia. Seventeen patients with COPO and hematocrits higher than 54 percent (mean Hct: 57 :t 0.49
percent ), who had not received anti-inflammatory or antiplatelet aggregation agents recently.Their mean forced expiratory volume at
1 second (FEV1) was 0.92:t 0.11 L. Intervention: Blood work was collected to evaluate the following: serum iron and ferritin leveis, total
iron binding capacity, transferrin saturation index, fibrinogen plasma leveis, activated partial thromboplastin time, platelet count, plate-
let aggregation measurements, and thromboelastography coagulation parameters. The blood samples were obtained before and
about 7 days after the hematocrit correction by 300-400 ml phlebotomies done every other day.The mean number of phlebotomies
done for each patient was 4.4. Postphlebotomy iron serum leveis decreased from 90.1 :t 14.8 to 59.7:t 9.9 mg/dl and the ferritin serum
leveis from 133.8 :t 37.9 to 70.8 :t 32.7 ng/ml (p< 0.05). Regarding the coagulation studies, there were significant increases in the
platelet count, from 227,300 :t 13,900 to 312,500 :t 30,200 per mm3, and in the maximum clot amplitude (a) obtained by
thromboelastography ( from 53.6 :t 1.4 percent to 60.4 :t 1.1 percent). The coagulation time (k) of the thromboelastography also
decreased significantly, from 7.5 :t 0.7mm prephlebotomy to 4.5 :t 0.3mm postphlebotomy. Although the coagulation changes were
small amount, the observed significant decrease in iron contents may have important clinicai implications.
UNITERMS: Secondary polycythemia; repetitive phlebotomies; iron deficiency; coagulation; chronic obstructive pulmonary disease
INTRODUCTION
B loodlettings, or phlebotomies, are still adyocatedin the care of chronic obstructive pulmonarydisease (COPD) patients with cor pulmonale and
severe secondary polycythemia.1 Several authors have
shown that hematocrit (Hct) reductions in hypoxemic
patients with COPD and polycythemia are followed by
improvement in general symptoms,2-S mental activity2-6 and
exercise performance.2-4.7.8
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In a group of patients performing exercise studies in
ergometer, the maximum workload and oxygen
consumption have increased 31 and 16 percent
respectively, when the mean Htc had decreased from 62
to 50 percent,x These effects are not secondary to changes
in respiratory mechanics or blood gases.2.4.S.7-10Rather, it
seems they result from improvements in hemodynamic
conditions related to a better blood viscosity.3.11-13
Although a great deal has been published in this field,
no attention has been paid to the potential hematological
consequences of phlebotomies. Similarly to what happens
with blood donors and during the treatment of
hemochromatosis, repeated phlebotomies in COPD
patients could lead to reductions in their iron body
contents.14.1S Iron deficiency states may run with
decrements in work performance secondary to drops in
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helTIoglobin leveIs, and disturbances in muscular oxidative
metaboIism.1ó In the case of reductions in iron body
contents actualIy deveIoping in COPD patients folIowing
phlebotomies, the former could act as limiting factors for
expected exercise improvements.
In addition, polycythemia is a welI known risk factor
for thrombosis,17 and lnany studies. suggest that COPD
patients have a higher tendency to have thromboembolic
episodes.IX-20 SOlne studies of thrombotic risk in COPD
have shown an increased tendency towards coagulation
with altered values in the throlnboelastogram,
hyperfibrinogemia and increased platelet aggregation.1x'21-23
Therefore, we hypothesized that a reduction in Hct leveIs
by phlebotolnies could aIso have a favorable effect on
decreasing s'uch thrombotic risk.
The present study investigates the effects of the Hct
correction by repeated phlebotomies on paralneters of
hemostasis and body iron contents in COPD patients with
severe secondary hypoxemic polycythemia.
PATIENTS AND METHODS
Patient Selection
Seventeen with COPD and polycythelnia ( Hct 54
percent or more) patients were studied after signing an
informed consent formo All patients were in stable
respiratory conditions, without clinicaI evidence of right or
left ventricular faiIure. They had not been under any
antiplatelet or anti-inflammatory agent for at least the prior
10 days, and.during the study period there were no changes
in their daily medications. None of the patients showed
clinicaI evidence ofblood loss or were using oxygen at that
time.
Following an initiallaboratory evaIuation, phlebotomies
of 300 to 400 ml were perfonned every other day until a
venous Hct value around 45 percent was reached (range: 41-
48 percent). A second set of laboratory tests was then
performed about 7 days after the last phlebotomy 'session.
Iron Stores Measurements
Venous blood samples with no anticoagulant were
collected from fasting patients in the Inorning. Iron seruln
leveIs and seruln total iron binding capacity (TIBC) were
measured using a commercialIy available kit (Iron Roche@)
with readings made with a Colelnan 6/20
spectrophotometer. Ferritin serum leveIs were also
evaluated by a commercially available enzymatic
immunoassay (FerrizYlne TM@- Abbot Laboratories). The
transferrin saturation index (TSI) was calculated as the
percentile ratio between serum iron leveIs and TIBC.
Coagulation Studies
Coagulation tests were performed on 3.8 percent
sodium citrate venous blood samples collected
simuItaneously with the iron blood work. The following
determinations were made:
- Activated paltial thromboplastin time (APTT) using
human cephalin.24 The results were expressed as the ratio
to the control values for the Iaboratory on that day.
- Fibrinogen plasma leveIs, assessed by the Ratnoff-
Menzie Inethocl.25
- PlateIet count, made in an automatic counter Clay
Adams modeI Ultra-FIo.
- Platelet aggregation determinations by the Born
lnethod in a Chronolog aggregometer.2ó The aggregation
agents ADP in concentrations of 1 mM and 3 mM,
epinephrine at 1:1000 dilution, and hUlnan colIagen were
used in salnples froln each patient. The percentage of
aggregated pIatelets was caIculated at a curve point
corresponding to an interval of 5 minutes from the initial.
stimulus for each aggregation agent.
- Throlnboelastography (TEG), using a Hartert
throlnboelastograph lnade by HelIige. This test exalnines
the entire bloocl coaguIation process and the interaction
of alI involvecl cOlnponents.27 The reaction tilne r, the
coagulation time k, and the lnaxil11um cIot alnpIitude a ,
were lneasured using a special ruIer on the developed filmo
Statistical Methods
All data are expressed as the mean :t standard error.
The WiIcoxon test was used in the statistical analysis for
the nonindependent variables. A. leveI of 5 percent was
fixed as the litnit for rejection of the null hypothesis.
RESULTS
Thirteen male and four female patients were studiecl.
Most of theln had severe or 1110derateCOPD with arterial
hypoxemia (Table 1). The mean Hct fell frol1157 percent
before phebotolnies to 45 percent at the time of the final
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Table 1
Patient Summary
Age FEV1 FVC/FEV1 Pa02 Hct Pre Hct Post
No. Gender yr L % mmHg % %
1 M 53 1.17 50 47 54 45
2 M 44 0.82 38 39 55 48
3 M' 60 0.71 35 44 54 44
4 M 63 0.59 31 49 57 45
5 M 44 0.65 38 45 60 45
6 F 36 0.47 47 42 57 41
7 M 50 1.46 50 46 63 44
8 F 72 0.48 45 38 56 46
9 M 28 0.57 36 42 58 47
10 M 75 1.19 45 49 60 47
11 M 67 1.41 60 53 58 44
12 M 70 1.68 60 51 55 45
13 F 42 0.65 32 46 56 43
14 F 68 0.44 37 49 58 44
15 M 70 0.62 35 53 57 46
16 M 35 1.88 49 52 55 45
17 M 66 0.93 28 59 55 42
Mean 55:t3.6 0.92:t .11 42:t2.4 47:t1.2 57:t.49 45:t.49
TIBC: serum total iron binding capacity; TSI: transferin saturation indexo
*p< 0.05
Table 2
Iron contents measurements (Mean :!: SE) obtained
pre-and postphlebotomy
There were significant decreases in the serunl leveIs
of iron, ferritin and TSI postphlebotolny (Table 2). Twelve
studies. The second set of blood tests were collected 8.7 :t
1.3 days after the Iast phlebotomy. The time between blood
collection and actuaI sample analysis was no longer than
two hours in every case.
Postphlebotomy
59.7:t 9.9*
399.9 :t 20.0
16.7:t 3.6*
Prephlebotomy
90.1 :t 14.8
393.6 :t 27.6
25.4 :t 4.9
Coagulation Studies
Coagulation studies obtained before and after
phlebotomies are listed in Table 3. Ali the initial Inean
values were within the norlnal limits' of the authors'
laboratory except for the r paralneter of the TEG, vvhich
was slightly increased. No significant decreases were seen
in the Inean APTT and fibrinogen leveIs after
phlebotolnies. The platelet count significantly increased
fronl 227,3001Inln3 to 312,000/mm3 after the procedure.
Fifteen patients (88.2 percent) showed an increase in the
Normal Range
50-150
200-400
20-50
Iron, mg/dl
TIBC, mg/dl
TSI, %
a decrease i n i ron
Iron Measurements
patients (70 percent) showed
concentrations and in 7 of these
it remained below 50 percent of
the initial value. Falls in ferritin
leveIs were seen in 16 patients
(94 percent). Such decreases
were greater than 50 percent
from the baseline values in 12
(70 percent) of the subjects. In
8 patients (47 percent), the final
ferritin values were below 10 ng/
Inl, indicating severe iron
depletion (Fig. 1).
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2). Serum ferritin is a good indicator of
iron body stores, and the drop in its leveIs
denotes that the tissue iron contents28,29
were also affected.
Iron deficiency states may have
effects on red blood cells and solid organ
tissues. Although it would be expected
that iron deficiency could have an
inhibitory effect on COPD hypoxic
hemopoietic response, this is not always
the case. Secondary polycythemia
associated to iron deficiency in COPD
patients has been described.30,31 Some
authors report that iro,n depletion may not
be an impeding factor to increases in red
cell mass, and that in such cases
polycythemia is associated with
hypochromic erythrocytes.32
An iron deficiency state may also
Figure 1- Iron and ferritin individual values for COPO patients submitted to sequencial di sturb the mu scular oxidati ve
phlebotomies. metabolism, interfering with the patient's
work performance. 16 The tissue haem iron
compounds include the cytoçhromes, myoglobin, catalase
and peroxidase. In additiQD, muscles harbor non-haem
iron-containing enzymes such as NADH dehydrogenase,
succinic dehydrogenase and xanthine oxidase. Finally,
some enzymes such as aconitase and tryptophan pyrrolase
require iron or haem as a cofactor.
Experimental studies on rats have found that mild
and severe iron deficiency are associated with deficits 9f
cytochrome c and mioglobin in skeletal muscle.33 FINCH
et a1.34 completed studies of work performance on iron-
deficient rats, keeping hemoglobin leveIs constant through
exchange transfusions. It was seen that iron-deficient rats
had a significant shorter running time than çontrols with
similar hemoglobin leveIs. After 4 days of iron
administration, the iron-deficient group achieved normal
running times.
Biochemical analysis done at that time suggested that
an increase in the rate of oxidative phosphorylation with
a-glycerophosphate as a substrate played a key role in the
improvement of work performance. Non-published data
from our laboratory have shown small but significant
increases in the maximal work load and oxygen
consumption reached by 15 iron-deficient, anemic wom'
4 days after administration ofIV iron-dextran, ev~n though
their hemoglobin leveIs had not changed.
Therefore, we can hypothesize that COPD patients
who show ameIioration of exercise performance after
phIebotomies lnight have this effect attenuated if
simuItaneous iron deficiency states deveIop. The
DISCUSSION
platelet count, 4 of them with final measurements beyond
400,OOO/mm.3 Studies of platelet aggregation made with
different stimulant agents did not show any significant
postphlebotomies change.
Adequate thromboelastography studies before and
after phIebotomies could not be obtained in 4 patients due
to technical problems. In the 13 studied subjects, a
significant decrease was noticed in k during the final
studies. Although r also experienced a decrease, such
change did not reach statistical significance. Finally, a
values showed a significant postphlebotomies increase.
Phlebotomy may be used in the care of COPD
patients in an attempt to reduce detrimental cardiovascular
effects of blood hyperviscosity due to polycythemia. The
basis for this procedure is the effect of phIebotomy in
improving hemodynamic conditions and exercise
performance in such patients.2-4,7,8,11-13 However, the effects
of this kind of therapy on hemostasis and iron reserves of
COPD patients had not been thoroughIy examined before.
Our present resuIts showed that the normalization of
hematocrits by phlebotomies led to an important reduction
in iron body contents. This became apparent by the
significant decreases in serum iron, ferritin and TSI (Table
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Table 3
Results of coagulation studies (Mean :!: SE) obtained pre-and postphlebotomy
Normal Range Prephlebotomy Postphlebotomy
APTT 0.90-1.25 1.14:t 0.06 1.06 :t 0.04
Fibrinogen, mg/dl 200-400 262:t 12 236.5 :t 13.2
Platelets/mm3 200,000-400,000 227,300:t 13,900 312,500:t 30.2*
Platelet Aggregation
ADP 3mM, % 60-80 65.8 :t 5.1 74.1 :t 3.9
ADP 1mM, % 60-80 63.0 :t 6.4 69.8 :t 4.7
Epinephrine, % 60-80 63.3 :t 6.4 64.6 :t 5.9
Collagen, % 60-80 80.0 :t 2.8 78.2 :t 3.2
Thromboelastography#
',mm 7.2-9.6 9.9 :t 0.7 9.0 :t 0.5
k,mm 5.8-7.8 7.5 :t 0.7 4.5 :t 0.3*
a,mm 48-60 53.6:t 1.4 60.4:t 1.1*
APTT: activated partial thromboplastin time; ADP: adenosine diphosphate; r: reaction time;
k coagulation time; a: maximum clot amplitude
*p < 0.05; # data from 13 patients
development of hypochromic red ceIls in such situations
could impair oxygen transport to the tissues, even with
the presence of a high hematocrit. Furthermore, iron
depletion at the skeletal muscle leveI could lead to poor
enzymatic function and oxygen utilization.
In order to evaluate the effects of Het correction by
phlebotomies on the hemostasis of COPD polycythemic
patients, tests were done to assess the intrinsic pathway,
platelet and fibrinogen concentrations, platelet aggregation
and TEG. A renewed interest in TEG monitoring has been
seen recently because its tracing represents the shear
elasticity of a blood clot as it forms, matures, retracts and
eventuaIIy lyses. This test is extremely sensitive to identify
hypercoagulabi lity. 27
The initial evaluation prephlebotomy did not show
any evidence of hypercoagulability, since most of the test
resuIts were within the normal range for our coagulation
laboratory (Table 3). The only exception was the reaction
time r, which represents the time required for initiaI fibrin
fornlation, which was slightly increased. This last finding
indeed is lnore compatible with a hypocoagulability
condition.
The mean platelet count increased significantly after
phlebotomy from 227,300 to 312,500 mm3 (Table 3).
Increases in platelet number have been reported after
chronic and acute blood 10ss.35.36The lnechanisms involved
in such rises may be related to iron depletion, since an
inhibitory effect of this metal in throbopoiesis has been
described.35 Other studies suggest the presence of an
humoral factor, the thrombopoietin, in plasma from animaIs
with posthemorrhagic thrombocytosis.37
In opposition to previous reports on COPD patients,
we did not observe an increase in platelet aggregation after
phlebotomy.'XJX-40Those reports attempted to relate their
findings to increases in circulating cathecolamines,
especial1y serotonin, secondary to the bleeding. The
differences between present and former results lnay be
explained by the fact that our blood samples were collected
later, around one week after the Iast phlebotomy, when
normalization of cathecolamine leveIs probably had
already occurred.
Other significant postphlebotomy changes were an
extension of a and shortening of k in the TEG tracings
(Table 3). The paralneter a represents the lnaximuln clot
strength. The parameter k represents the ~peed of clot
forlnation, fibrin crosslinking and platelet-fibrin
interaction. Both parameters may be decreased in cases of
throlnbocytopenia or hypofibrinogenemia. Although with
no statistical significance, the r value also decreased
postphlebotomy.
These last results suggest that improvements in
thrombin fonnation have occurred postphlebotomy. This
could be a non-specific reaction to bleeding, as increases
in coagulation activity measured by TGE following blood
MARTINEZ, J.A.B.; GUERRA,C.C.C,; NERY, L.E. et aI. - Iron stores and coagulation
parameters in patients with hypoxemic polycythemia secondary to chronic obstructive
pulmonary disease: The effect of phlebotomies
São Paulo Medicai Journal/RPM 115(2): 1395-1402, 1997
1400
losses during surgery have been described.41 Such changes
were documented even 2 hours after surgery and could
have accounted for cathecolamine releases related to stress,
and the entry into circulation of coagulation factors froln
the hepatic interstitial fluido However, our final coagulation
tests were performed about 7 days after the last
phlebotomy, again making this interpretation less probable.
Another possibility is that decreased helnatocrits led to
falls in viscosity with better liver perfusion and
oxygenation, promoting improvelnent its production of
coagulation factors.
The increase in a Inay also be related to the
en)argement' of the platelet counting. Although the
fibrinogen leveIs have not changed, the growth in a
postphlebotomy may also be in part secondary to a higher
availability of fibrinogen for the fibrin network making.
In high Hct samples, the total alnount of fibrinogen may
not be enough to make a fibrin network capable of strongly
containing an increased nUlnber of red cells. Low Hct
samples may have proportionally Inore fibrinogen to be
used in the fibrin network, producing clots with greater
texture.
In summary, the coagulation tests made after
phlebotolny have shown slnall changes towards an
augmented coagulability. Such changes could be the result
of an organic reaction to bleeding, especially the increase
in platelet counting. Although the precise clinicaI meaning
of these findings are unknown, the literature contains a
reference to a patient with pulmonary artery thrombosis
following phlebotomies.42 However, alnong the different
tests done, only k reached a final value out of our normal
laboratory range. Therefore, we speculate that the detected
changes do not represent a harmful thrombotic risk related
to the phlebotomies
Based in the present results, we do oot think the
prophylactic adlninistration of anticoagulant agents after
phlebotomies in COPD patients is necessary. In addition,
we recolnmend oral iron supplementation after
phlebotolnies for polycythelnic COPD patients in order
to avoid iron deficiency.
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